DJIA 18,037.97 -42.17 -0.23%
NASDAQ 5,060.25 -31.84 -0.63%
S&P 500 2,108.92 -8.77 -0.41%
market minute promo

Novartis (NYSE: NVS)

103.91 -0.37 (-0.35%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVS $103.91 -0.35%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $104.99
Previous Close $104.28
Daily Range $103.86 - $105.50
52-Week Range $84.17 - $105.82
Market Cap $249.2B
P/E Ratio 28.18
Dividend (Yield) $2.67 (2.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,424,036
Average Daily Volume 1,369,054
Current FY EPS $5.25




Drug Makers

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website:

News & Commentary

Are Biosimilars the Next Big Thing in Biotech?

Biosimilars could soon become a major force in biotech as multiple top-selling biologics lose patent protection. So are biosimilars the next big thing in biotech, or are they overhyped?

Today's Top Performers In Drugs

Teva-Active Biotech Start Phase II on MS Drug - Analyst Blog

Novartis (NVS) Beats on Earnings in Q1, View Reiterated - Analyst Blog

Novartis (NVS) Beats on Earnings in Q1, View Reiterated - Analyst Blog

Novartis AG (NVS) Earnings Report: Q1 2015 Conference Call Transcript

Novartis's (NVS) CEO Joe Jimenez on Q1 2015 Results - Earnings Call Transcript

Amgen Reports An Upbeat Q1 Earnings

Novartis (NVS) Beats on Earnings & Revenues - Tale of the Tape

Novartis Posts Higher Q1 Profit

Amgen's Q1 Earnings Paints An Overall Positive Image To Investors

See More NVS News...

NVS's Top Competitors

NVS $103.91 (-0.35%)
Current stock: NVS
JNJ $100.58 (-0.49%)
Current stock: JNJ
MRK $57.10 (-0.87%)
Current stock: MRK
GSK $46.85 (0.56%)
Current stock: GSK